CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Egile nagusia: | Eva, Israt Ara Jannat |
---|---|
Beste egile batzuk: | Rahman, Kazi Fatema |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2023
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/17764 |
Antzeko izenburuak
-
A review on CRISPR-Cas system based applications in Oncology
nork: Sadia, Mir
Argitaratua: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
nork: Maria, Amatul
Argitaratua: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
nork: Nwabunwanne, Eze Uchenna
Argitaratua: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
nork: Shaikat, Mahdi Mubin
Argitaratua: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
nork: Ullah, Mohammad
Argitaratua: (2023)